Xinhua Opinion: Focus On Hospital Reforms To Lower China Drug Costs
This article was originally published in PharmAsia News
Executive Summary
Xinhua said in an opinion piece the widening investigations into alleged wrongdoing in the China drug market will not be enough and called for even greater reforms in the hospital business model.